Grant: Project Grant - Priority Announcement: Infection and Immunity
University of Calgary
$100,000.00
Investigation of Hepatitis B Virus Immunopathogenesis using Intravital Microscopy in the Woodchuck Hepatitis Virus (WHV) Model of Hepatitis B
EF 2021-22
Résumé
The hepatitis B virus (HBV) is a major cause of severe liver disease worldwide, including cirrhosis and liver cancer. There are drugs that can control the virus but they do not cure chronic infection. Babies born to mothers with HBV infection are up to >95% risk of developing a life-long (persistent) infection without timely vaccination. Most people with early (acute) infection do not have symptoms and there are few studies in patients. There is a need for greater understanding of the immune response after exposure to virus, in the early infection and during chronic infection in order to develop better therapies. Some subspecies of woodchucks (groundhogs) can be infected with woodchuck hepatitis virus (WHV) a cousin of the HBV, and also develop hepatitis (liver inflammation) and liver cancer similar to people. WHV infection in woodchucks is a valuable model helping to understand how liver disease and cancer develops, as well as for testing of new antiviral drugs. Until now, most assessments of the immune response to HBV infection and to treatment were done by evaluating surrogate markers in blood. We will use standard tests of blood and liver tissue to assess the immune response to infection in young and adult animals, either untreated or on treatment. We will complement these assays using advanced live cell imaging within the liver to assess in real time the immune response to early and long-term WHV infection before after drug treatment. Our team are experts in liver disease, virology, HBV pathogenesis, in the woodchuck HBV model, and in using live cell imaging. We will assess, for the first time, virus-cell and cell-cell interactions inside the living liver in response to virus infection, in different stages of liver disease and during treatment. This study will ultimately contribute to the development of new treatments aiming to achieve a cure for chronic hepatitis B and, therefore, capable of complete protection against liver cancer caused by HBV.
Programme
Project Grant - Priority Announcement: Infection and Immunity
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
447669
Name
Coffin Carla S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Investigation of Hepatitis B Virus Immunopathogenesis using Intravital Microscopy in the Woodchuck Hepatitis Virus (WHV) Model of Hepatitis B
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Infection and Immunity
Keyworddelim
Acute And Chronic Hepatitis Infection; Cytokines; Hepatitis B Virus; Immunohistochemistry And Histology; Immunomodulatory Therapy; Intravital Microscopy; Liver Cancer And Liver Disease; Nucleos(T)Ide Analog Therapy; Peripheral Blood Mononuclear Cells; Woodchuck Hepatitis Virus
Abstract
The hepatitis B virus (HBV) is a major cause of severe liver disease worldwide, including cirrhosis and liver cancer. There are drugs that can control the virus but they do not cure chronic infection. Babies born to mothers with HBV infection are up to >95% risk of developing a life-long (persistent) infection without timely vaccination. Most people with early (acute) infection do not have symptoms and there are few studies in patients. There is a need for greater understanding of the immune response after exposure to virus, in the early infection and during chronic infection in order to develop better therapies. Some subspecies of woodchucks (groundhogs) can be infected with woodchuck hepatitis virus (WHV) a cousin of the HBV, and also develop hepatitis (liver inflammation) and liver cancer similar to people. WHV infection in woodchucks is a valuable model helping to understand how liver disease and cancer develops, as well as for testing of new antiviral drugs. Until now, most assessments of the immune response to HBV infection and to treatment were done by evaluating surrogate markers in blood. We will use standard tests of blood and liver tissue to assess the immune response to infection in young and adult animals, either untreated or on treatment. We will complement these assays using advanced live cell imaging within the liver to assess in real time the immune response to early and long-term WHV infection before after drug treatment. Our team are experts in liver disease, virology, HBV pathogenesis, in the woodchuck HBV model, and in using live cell imaging. We will assess, for the first time, virus-cell and cell-cell interactions inside the living liver in response to virus infection, in different stages of liver disease and during treatment. This study will ultimately contribute to the development of new treatments aiming to achieve a cure for chronic hepatitis B and, therefore, capable of complete protection against liver cancer caused by HBV.
Competitiondate
202104
Approvedterm2
1 yr 0 mth
Pinamesdelim
Coffin, Carla S; Jenne, Craig N; Michalak, Thomas I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~